Cardiovascular
Medicine
Is Dental Clearance before Cardiac Surgery Necessary?
Further Education Cardiac and Thoracic Vascular Surgery Cardiology Prevention and Public Health
Overestimated Preoperative Routine
Peer-review

Is Dental Clearance before Cardiac Surgery Necessary?

Original Article
Further Education Cardiac and Thoracic Vascular Surgery Cardiology Prevention and Public Health
Mevlüt Çelika
Additional authors
Maria Nuceraa, Fabio Pregaldinia, Clarence Pingpoha, Thomas Pilgrimb, Matthias Siepea, David Reinekea
Issue
2024/02
DOI:
https://doi.org/10.4414/cvm.2024.1356564558
Cardiovasc Med. 2024;27(02):47-51
Data Supplement
Addendum.doc
Affiliations
a Department of Cardiac Surgery, University Hospital Inselspital Bern, University of Bern, Switzerland
b Department of Cardiology, University Hospital Inselspital Bern, University of Bern, Switzerland

Published on 27.03.2024

Abstract

Background: Dental clearance is routinely performed before cardiac surgery, as it is thought to be essential in reducing postoperative bacteremia and endocarditis. However, there is a lack of evidence supporting this routine.
Objectives: This study aimed to investigate the impact of dental clearance on postoperative outcomes after cardiac surgery.
Methods: This is a comprehensive review and analysis of relevant studies published between January 1, 1990 and January 1, 2023 in two electronic databases (PubMed and EMBASE). Pooled estimates in terms of relative risk (RR) or standardized mean difference were calculated according to outcome measures. Risk of bias and quality of studies were evaluated. A total of 7040 articles were found through the MEDLINE, EMBASE and Cochrane databases. Five articles were found to be eligible for inclusion in this review.
Results: There is no statistically significant benefit of preoperative dental clearance in terms of postoperative outcomes, including all-cause mortality (RR 0.92, 95% Confidence Interval [CI] 0.43–1.97), prosthetic valve endocarditis (RR 1.32, 95% CI 0.51–3.43), postsurgical infection (RR 1.02, 95% CI 0.77–1.36), and length of hospital stay (weighted mean difference 4.00, 95% CI -2.70–10.70).
Conclusions: Although the literature emphasizes the importance of preoperative dental clearance, no significant effect was seen with respect to all-cause mortality, infection, endocarditis, and length of hospital stay.
Keywords: Dental clearance; heart valve surgery; LVAD; mortality; prosthetic valve endocarditis

Introduction

In many cardiac surgery facilities, dental status is part of the routine assessment prior to valve surgery or interventions using prostheses, since the oral cavity serves as a potential reservoir for pathogens with the capacity to induce systemic infections. The presence of untreated dental infections, such as dental caries, periodontal disease or oral abscesses can cause bacteremia and are therefore seen as a substantial hazard for postoperative complications, including endocarditis, mediastinitis, prosthetic valve infections and subsequent mortality. The prevalence of prosthetic valve endocarditis (PVE) is low, ranging from 1 to 6% [1]. However, it represents a critical and potentially fatal complication with a mortality rate of up to 40%, and it is commonly associated with specific bacterial strains, including Viridans group streptococci, Streptococcus bovis, Haemophilus spp., Aggregatibacter actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Kingella kingae, Kingella denitrificans, Staphylococcus aureus and community-acquired enterococci when no primary focus is present [2–4]. The majority of these bacterial species are considered commensal inhabitants of the oral-pharyngeal region. As the oral cavity is not an isolated entity, dental caries, periodontal disease and oral infections can lead to systemic consequences [5].
Cardiac surgery with the use of extracorporeal circulation promotes the release of pro-inflammatory cytokines. This inflammatory cascade has the potential to aggravate preexisting oral infections, thereby facilitating the contamination of cardiac valves or prosthetic materials. Due to this oral-systemic connection, dental clearance is supported by American and European endocarditis guidelines alike. They strongly recommend that “potential sources of dental sepsis should be eliminated at least 2 weeks before implantation of a prosthetic valve or other intracardiac or intravascular foreign material…” (Class IIa, Level of Evidence C per American guidelines) [1, 2]. However, the most recent European endocarditis guideline does not make a clear statement regarding preoperative dental clearance anymore due to insufficient evidence [6].
The aim of this meta-analysis was to see whether existing data supports the routine performance of preoperative dental clearance.

Methods

To provide a clear structure and ensure transparent reporting, this study complies with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines [7, 8].

Search Strategy and Study Inclusion

The MEDLINE, EMBASE and Cochrane databases were searched up to January 1, 2023 for full-length publications in English reporting on patients undergoing preoperative dental clearance before cardiac surgery. The search strategy is provided in the supplementary material (fig. S1). Because the data-sharing statements indicate confidentiality, authors were not contacted if the provided data was unclear. Studies by the same author, except for guidelines, letters, position papers, consensus statements and reviews, were included. First, the title and abstract were reviewed, then the remaining articles were reviewed in depth. Relevant articles identified by cross-referencing were added manually to ensure that no relevant studies were missed. A study was included if: (i) the patients were preoperatively screened; (ii) it included any outcomes after any type of predefined cardiac surgery; and (iii) the participants were adults.

Data extraction

After identifying relevant articles, we extracted clinically relevant data and data necessary for inclusion. In case of any disagreements, consensus was reached through discussion. The extracted study description data included location and design of the study, the number of included patients, the time span of patient inclusion, the time between preoperative dental clearance and following procedures, and relevant outcomes. The primary endpoints were all-cause mortality, incidence of PVE, post-surgical infection and length of hospital stay. We extracted total follow-up time, mean or median follow-up time and the number of events that occurred during this follow-up period for our endpoints.

Statistical analysis

Descriptive statistics were summarized as mean ± standard deviation or crude numbers with percentages, where appropriate. The primary endpoints of this study were the difference in all-cause mortality, the incidence of PVE, post-surgical infection and the length of hospital stay.
The data was analyzed using ReviewManager Version 5.3 (Cochrane, London). Overall risk ratio and risk differences were calculated using a dichotomous setting with an inverse variance and, due to the expected heterogenicity, a random effects model was chosen. The heterogeneity was calculated using the I2 and chi-squared coefficients. The confidence interval (CI) was set at 95%.

Results

Search Results

A total of 7040 articles were found through the MEDLINE, EMBASE and Cochrane databases. After removing duplicates and evaluating the titles and abstracts, 181 studies underwent a thorough examination of the full text. Four articles were found to be eligible for inclusion. A search of the references resulted in the inclusion of one additional study. The screening process is visually depicted in figure S1, adhering to the guidelines outlined by PRISMA. In the end, five studies were included in the review [9–13].
Figure S1: Flowchart of included studies.

Included Studies

Table 1 and 2 depict the baseline characteristics and outcomes of the included studies.

Outcomes: All-cause Mortality

Among the included studies, four investigations provided data on all-cause mortality. In the meta-analysis the pooled relative risk (RR) was calculated to be 0.92 (95% CI 0.43–1.97), indicating a very low certainty of evidence (fig. 1) [9–12]. The RR suggests that there may be no discernible difference in the risk of all-cause mortality between individuals who underwent dental clearance before cardiac surgery and those who did not. There was moderate heterogeneity between the studies (p = 0.83, I2 = 47%). The included studies were downgraded to a very low certainty of evidence for this outcome due to concerns regarding the bias risk.
Figure 1: Risk Ratio for all-cause mortality after dental clearance.
CI: Confidence Interval.

Outcomes: Prosthetic Valve Endocarditis

Among the studies included in our analysis, three investigations provided data on the rates of prosthetic valve infective endocarditis [9, 12, 13] The pooled estimate from these studies yielded a RR of 1.32 (95% CI 0.51–3.43), indicating a very low certainty of evidence (fig. 2). There was moderate heterogeneity between the studies (p = 0.56, I2 = 32%). The RR of 1.32 might suggest a potentially increased risk of developing prosthetic valve endocarditis for individuals who underwent dental clearance compared to those who did not, although the difference is not statistically significant.
Figure 2: Risk Ratio for prosthetic valve endocarditis after dental clearance.
CI: Confidence Interval.

Outcomes: Postsurgical Infection

The rates of postsurgical infection were reported in two studies [10, 13]. A pooled RR of 1.02 (95% CI 0.77–1.36) was calculated, with a very low certainty of evidence, suggesting that there are no significant difference in the rate of postsurgical infection between individuals who received dental treatment before heart valve surgery and those who did not (fig. 3). There was low heterogeneity between the studies (p = 0.89, I2 = 0%).
Figure 3: Risk Ratio for postsurgical infection after dental clearance.
CI: Confidence Interval.

Outcomes: Length of Stay

Among the included studies, three investigations provided data on the mean length of stay (LOS), ranging from 15 to 20 days [9, 10, 12]. Conducting a meta-analysis of this data, the estimated weighted mean difference in LOS was calculated to be 4.0 days (95% CI -2.7–10.7) (fig. 4). There was considerable heterogeneity between the studies (p = 0.24, I2 = 93%). It is important to note that there is substantial heterogeneity in the estimates across the studies. However, due to the limited number of studies available and the lack of variability in the predefined clinical aspects of these studies, it was not possible to investigate the source of this heterogeneity.
Figure 4: Weighted mean difference in length of stay at the hospital after dental clearance.
CI: Confidence Interval.

Discussion

This study describes the association between preoperative dental clearance and subsequent postoperative outcomes. We found no difference in all-cause mortality, incidence of postoperative endocarditis, postoperative infection and length of hospital stay after preoperative dental clearance before cardiac surgery. The current available evidence points to an unestablished association, leaving us without a clear understanding of whether preoperative dental clearance leads to a lower incidence of postoperative endocarditis. This lack of certainty primarily stems from two critical factors: the absence of adjusted analyses accounting for potential confounding variables and issues leading to imprecision due to population size.
After cardiac surgery, particularly after prosthetic heart valve replacement, patients have an increased risk of postoperative endocarditis. The current practice of preoperative dental clearance relies on retrospective data. As mentioned before, the American Endocarditis guidelines recommend that “potential sources of dental sepsis should be eliminated at least 2 weeks before implantation of a prosthetic valve or other intracardiac or intravascular foreign material…” (Class IIa, Level of Evidence C per American guidelines) [2]. However, the current European guideline does not support dental clearance due to missing evidence [6].
In our meta-analyses among the included studies, the pooled RR of all-cause mortality was 0.92 (95% CI 0.43–1.97). This wide range may be attributed to differences in late-term mortality and the limited follow-up period in two of the four included studies. In previous population studies, oral health conditions were associated with long-term mortality [14]. However, bias stemming from poor oral health, which could potentially serve as an indicator for the overall health status or directly impact long-term survival, might be influencing these findings.
Existing data regarding dental clearance prior to various interventional modalities has shown insufficient data. Kouwenberg et al. investigated dental treatment prior to aortic valve surgery and, given the limited evidence available, about whether preoperative dental clearance might reduce the risk of postoperative endocarditis [15]. The studies included in this meta-analysis showed significant heterogeneity in terms of methodologies, patient populations and dental clearance protocols. The authors solely focused on assessing postoperative PVE, which provides an incomplete perspective on potential postoperative complications. The studies generally had a short follow-up period, potentially contributing to the low incidence of PVE. Furthermore, variations in population characteristics could influence the PVE incidence. Notably, males tend to exhibit a higher incidence of periodontitis, oral cancer and worse oral hygiene, and might therefore have an increased tendency to develop PVE [16, 17]. Due to small populations, a subgroup analysis was not performed.
Preoperative dental clearance may even lead to unexpected negative outcomes. Patients undergoing heart surgery often present with both physical and psychological comorbidities, and dental procedures can introduce additional burdens, potentially worsening preexisting conditions [18, 19]. In case of heart valve surgery, dental screening led to stress-causing tooth extractions in 44% of patients [20]. Treating dental infections surgically may require changes in medication or prophylactic antibiotics, which can be inconvenient for patients [21]. Not all patients have easy access to dental care, especially those without dental insurance or in underserved areas. Therefore, requiring dental clearance can create barriers, potentially delaying a needed cardiac operation. Furthermore, dental procedures, event routine ones, carry risks of complication such as infection, bleeding and adverse reactions to anesthesia. Patients then have to deal with these complications in addition to the risks associated with cardiac surgery.
It is crucial to recognize several noteworthy limitations in the performed review. The first concern is the relatively small number of available studies, resulting in a very low certainty of evidence due to imprecision. Secondly, due to the small number of patients included in each study, significant baseline variables, such as smoking history, sex and age could not be accounted for. Despite these limitations, we have synthesized the available body of knowledge to provide valuable insights for clinical decision-making.
Based on the available evidence, it remains uncertain whether patients undergoing professional dental clearance prior to cardiac surgery can expect superior or inferior postoperative outcomes compared to those who do not receive (routine) oral health care.

Conclusion

Based on the, albeit very low amount of available evidence, there appears to be limited benefit of preoperative dental clearance with regards to postoperative outcomes such as mortality, incidence of postoperative endocarditis and infection, and length of hospital stay.
Mevlüt Çelik, MD PhD
University of Bern
Bern Department of Cardiac Surgery
Inselspital
Freiburgstrasse 18
CH-3010 Bern
mevluet.celik[at]insel.ch
1 Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015 Nov;36(44):3075–128.
2 Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr., Tleyjeh IM, Rybak MJ, et al.; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015 Oct;132(15):1435–86.
3 Durack DT, Lukes AS, Bright DK; Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994 Mar;96(3):200–9.
4 Abegaz TM, Bhagavathula AS, Gebreyohannes EA, Mekonnen AB, Abebe TB. Short- and long-term outcomes in infective endocarditis patients: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2017 Dec;17(1):291. Erratum in: BMC Cardiovasc Discord. 2018 Jan;18(1):5.
5 Giacaman RA, Fernández CE, Muñoz-Sandoval C, León S, García-Manríquez N, Echeverría C, et al. Understanding dental caries as a non-communicable and behavioral disease: Management implications. Front Oral Health. 2022 Aug;3:764479.
6 Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023 Oct;44(39):3948–4042.
7 Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021 Mar;10(1):89.
8 Brooke BS, Schwartz TA, Pawlik TM. MOOSE Reporting Guidelines for Meta-analyses of Observational Studies. JAMA Surg. 2021 Aug;156(8):787–8.
9 Wu GH, Manzon S, Badovinac R, Woo SB. Oral health, dental treatment, and cardiac valve surgery outcomes. Spec Care Dentist. 2008;28(2):65–72.
10 Nakamura Y, Tagusari O, Seike Y, Ito Y, Saito K, Miyamoto R, et al. Prevalence of periodontitis and optimal timing of dental treatment in patients undergoing heart valve surgery. Interact Cardiovasc Thorac Surg. 2011 May;12(5):696–700.
11 Bratel J, Kennergren C, Dernevik L, Hakeberg M. Treatment of oral infections prior to heart valve surgery does not improve long-term survival. Swed Dent J. 2011;35(2):49–55.
12 de Souza AF, Rocha AL, Castro WH, Ferreira FM, Gelape CL, Travassos DV, et al. Dental care before cardiac valve surgery: Is it important to prevent infective endocarditis? Int J Cardiol Heart Vasc. 2016 Jul;12:57–62.
13 Hakeberg M, Dernevik L, Gatzinsky P, Eklöf C, Kennergren C, Jontell M. The significance of oral health and dental treatment for the postoperative outcome of heart valve surgery. Scand Cardiovasc J. 1999;33(1):5–8.
14 Kim JK, Baker LA, Davarian S, Crimmins E. Oral health problems and mortality. J Dent Sci. 2013 Jun;8(2):115–20.
15 Kouwenberg AJ, Mensink G, Van Geldorp MV, Schaap J, Bentvelsen RG, et al. Do dental screening and treatments prior to heart valve interventions help prevent prosthetic valve endocarditis? A systematic review. J Dent Probl Solut. 2022 Dec;9(2):055–061.
16 Lipsky MS, Su S, Crespo CJ, Hung M. Men and Oral Health: A Review of Sex and Gender Differences. Am J Mens Health. 2021 May-Jun;15(3):15579883211016361.
17 Bhandari R, Tiwari S, Alexander T, Annie FH, Kaleem U, Irfan A, et al. Sex Differences in Characteristics of Patients with Infective Endocarditis: A Multicenter Study. J Clin Med. 2022 Jun;11(12):3514.
18 Stoppe C, Goetzenich A, Whitman G, Ohkuma R, Brown T, Hatzakorzian R, et al. Role of nutrition support in adult cardiac surgery: a consensus statement from an International Multidisciplinary Expert Group on Nutrition in Cardiac Surgery. Crit Care. 2017 Jun;21(1):131.
19 Chermesh I, Hajos J, Mashiach T, Bozhko M, Shani L, Nir RR, et al. Malnutrition in cardiac surgery: food for thought. Eur J Prev Cardiol. 2014 Apr;21(4):475–83.
20 Scott BJ, Leung KC, McMillan AS, Davis DM, Fiske J. A transcultural perspective on the emotional effect of tooth loss in complete denture wearers. Int J Prosthodont. 2001;14(5):461–5.
21 Lockhart PB, Loven B, Brennan MT, Fox PC. The evidence base for the efficacy of antibiotic prophylaxis in dental practice. J Am Dent Assoc. 2007 Apr;138(4):458-74; quiz 534–5, 437.
22 Smith MM, Barbara DW, Mauermann WJ, Viozzi CF, Dearani JA, Grim KJ. Morbidity and mortality associated with dental extraction before cardiac operation. Ann Thorac Surg. 2014 Mar;97(3):838–44.
23 Lund JP, Drews T, Hetzer R, Reichart PA. Oral surgical management of patients with mechanical circulatory support. Int J Oral Maxillofac Surg. 2002 Dec;31(6):629–33.
24 Meyer U, Weingart D, Deng MC, Scheld HH, Joos U. Heart transplants – assessment of dental procedures. Clin Oral Investig. 1999 Jun;3(2):79–83.
Conflict of Interest Statement
The authors MC, MN, FP, CP and MS have no potential conflicts of interest to declare.
TP reports grants to the institution from Biotronik and Edwards Lifesciences. He received honoraria for lectures, presentations or speaker fees from Abbott, Biotronik, Edwards Lifesciences, HighLife SAS and Medtronic. TP is a member of the Data Safety Monitoring Board of the EMPIRE trial investigating Biosensors and received equipment, materials or gifts from ATSense.
DR received travel expenses from Abbott, Edwards Lifesciences and Medtronic.
Funding Statement
This study was performed without funding.
Author Contributions
MC, MS and DR contributed to the design and implementation of the research, to the analysis of the results and to the writing of the manuscript. All authors discussed the results and commented on the manuscript.
Data Availability Statement
Data will not be made available to others.

Published under the copyright license.

"Attribution - Non-Commercial - NoDerivatives 4.0"

No commercial reuse without permission.

See: emh.ch/en/emh/rights-and-licences/

 

 

To the top